Genetically Engineered Swine Flu Virus (Patent)

Genetically Engineered Swine Flu Virus (Patent)

Genetically Engineered Swine Influenza Virus and Uses Thereof
Peter Palese et al.
Patent US20090010962

The present invention relates, in general, to attenuated swine influenza
viruses having an impaired ability to antagonize the cellular interferon
(IFN) response, and the use of such attenuated viruses in vaccine and
pharmaceutical formulations. In particular, the invention relates to
attenuated...

Inventors:
Peter Palese, Adolfo Garcia-Sastre, Richard J. Webby,
Juergen A. Richt, Robert G. Webster, Kelly M. Lager

Assignees:
MOUNT SINAI SCHOOL OF MEDICINE OF NEW YORK
UNIVERSITY, ST. JUDE CHILDREN'S RESEARCH HOSPITAL, THE
UNITED STATED OF AMERICA AS REPRESENTED BY THE
SECRETARY OF AGRICULTURE

Application number: 11/628,292
Publication number: US 2009/0010962 A1
Filing date: Jun 1, 2005

tags: swine flu, pig flu, hog flu, SIV, S-OIV, H1N1, H1N2, H3N1, H3N2, H2N3, patent, US20090010962, vaccine, IFN, Palese, virus